Global Medical Anti-Thrombotic Coating Market Growth 2026-2032
The global Medical Anti-Thrombotic Coating market size is predicted to grow from US$ 2093 million in 2025 to US$ 4218 million in 2032; it is expected to grow at a CAGR of 10.6% from 2026 to 2032.
In 2025, global Medical Anti-Thrombotic Coating production reached approximately 23.26 k tons, with an average global market price of around US$92,000 per ton.
The gross profit margin of major companies in the industry is between 45%–65%.
In 2025, the global production capacity of medical anti-thrombotic coating was approximately 31.01 k tons.
Medical Anti-Thrombotic Coatings are specialized surface treatments applied to blood-contacting medical devices to reduce platelet adhesion, coagulation, and thrombus formation. These coatings typically utilize heparin-based, hydrophilic polymer, or bioactive formulations to improve hemocompatibility and device safety. They play a critical role in cardiovascular and interventional procedures by lowering the risk of clot-related complications and improving clinical outcomes.
The industrial chain of Medical Anti-Thrombotic Coatings includes upstream bioactive agents, polymers, solvents, and surface modification materials. The midstream focuses on coating formulation, surface treatment processes, curing, and quality validation. Downstream applications cover catheters, guidewires, stents, vascular grafts, extracorporeal circulation devices, and implantable medical products, supported by regulatory compliance, validation testing, and technical services.
The medical anti-thrombotic coating market is driven by the rapid growth of cardiovascular diseases, aging populations, and increasing use of minimally invasive medical devices. As interventional procedures expand, demand for improved blood compatibility and device safety continues to rise. Anti-thrombotic coatings help reduce procedural risks and improve long-term performance of implanted and disposable devices. Advances in polymer science and bioactive materials enable more durable and multifunctional coating solutions. Regulatory emphasis on patient safety further accelerates adoption. Overall, the market is expected to grow steadily as medical device innovation and clinical demand for safer blood-contacting devices continue to increase.
LP Information, Inc. (LPI) ' newest research report, the “Medical Anti-Thrombotic Coating Industry Forecast” looks at past sales and reviews total world Medical Anti-Thrombotic Coating sales in 2025, providing a comprehensive analysis by region and market sector of projected Medical Anti-Thrombotic Coating sales for 2026 through 2032. With Medical Anti-Thrombotic Coating sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Anti-Thrombotic Coating industry.
This Insight Report provides a comprehensive analysis of the global Medical Anti-Thrombotic Coating landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Anti-Thrombotic Coating portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Anti-Thrombotic Coating market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Anti-Thrombotic Coating and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Anti-Thrombotic Coating.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Anti-Thrombotic Coating market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Medical Anti-Thrombotic Coating market?
What factors are driving Medical Anti-Thrombotic Coating market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Anti-Thrombotic Coating market opportunities vary by end market size?
How does Medical Anti-Thrombotic Coating break out by Type, by Application?
In 2025, global Medical Anti-Thrombotic Coating production reached approximately 23.26 k tons, with an average global market price of around US$92,000 per ton.
The gross profit margin of major companies in the industry is between 45%–65%.
In 2025, the global production capacity of medical anti-thrombotic coating was approximately 31.01 k tons.
Medical Anti-Thrombotic Coatings are specialized surface treatments applied to blood-contacting medical devices to reduce platelet adhesion, coagulation, and thrombus formation. These coatings typically utilize heparin-based, hydrophilic polymer, or bioactive formulations to improve hemocompatibility and device safety. They play a critical role in cardiovascular and interventional procedures by lowering the risk of clot-related complications and improving clinical outcomes.
The industrial chain of Medical Anti-Thrombotic Coatings includes upstream bioactive agents, polymers, solvents, and surface modification materials. The midstream focuses on coating formulation, surface treatment processes, curing, and quality validation. Downstream applications cover catheters, guidewires, stents, vascular grafts, extracorporeal circulation devices, and implantable medical products, supported by regulatory compliance, validation testing, and technical services.
The medical anti-thrombotic coating market is driven by the rapid growth of cardiovascular diseases, aging populations, and increasing use of minimally invasive medical devices. As interventional procedures expand, demand for improved blood compatibility and device safety continues to rise. Anti-thrombotic coatings help reduce procedural risks and improve long-term performance of implanted and disposable devices. Advances in polymer science and bioactive materials enable more durable and multifunctional coating solutions. Regulatory emphasis on patient safety further accelerates adoption. Overall, the market is expected to grow steadily as medical device innovation and clinical demand for safer blood-contacting devices continue to increase.
LP Information, Inc. (LPI) ' newest research report, the “Medical Anti-Thrombotic Coating Industry Forecast” looks at past sales and reviews total world Medical Anti-Thrombotic Coating sales in 2025, providing a comprehensive analysis by region and market sector of projected Medical Anti-Thrombotic Coating sales for 2026 through 2032. With Medical Anti-Thrombotic Coating sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Anti-Thrombotic Coating industry.
This Insight Report provides a comprehensive analysis of the global Medical Anti-Thrombotic Coating landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Anti-Thrombotic Coating portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Anti-Thrombotic Coating market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Anti-Thrombotic Coating and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Anti-Thrombotic Coating.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Anti-Thrombotic Coating market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Thin Coating
- Thick Coating
- Dip-Coated Anti-Thrombotic Layer
- Spray-Coated Anti-Thrombotic Layer
- Plasma-Deposited Coating
- Short-Term Blood-Contact Coating
- Long-Term Implantable Coating
- Controlled-Degradation Coating
- Catheter
- Stent Delivery System
- Guide Wire
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- DSM Biomedical
- Surmodics
- Specialty Coating Systems (SCS)
- Biocoat
- Coatings2Go
- Thermal Spray Technologies
- Hydromer
- Harland Medical Systems
- AST Products
- Precision Coating
- Surface Solutions Group
- ISurTec
- Whitford
- AdvanSource Biomaterials
- Jiangsu Biosurf Biotech
- jMedtech
What is the 10-year outlook for the global Medical Anti-Thrombotic Coating market?
What factors are driving Medical Anti-Thrombotic Coating market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Anti-Thrombotic Coating market opportunities vary by end market size?
How does Medical Anti-Thrombotic Coating break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medical Anti-Thrombotic Coating Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Medical Anti-Thrombotic Coating by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Medical Anti-Thrombotic Coating by Country/Region, 2021, 2025 & 2032
2.2 Medical Anti-Thrombotic Coating Segment by Type
2.2.1 Thin Coating
2.2.2 Thick Coating
2.2.3 Medical Anti-Thrombotic Coating Sales by Type
2.2.3.1 Global Medical Anti-Thrombotic Coating Sales Market Share by Type (2021-2026)
2.2.3.2 Global Medical Anti-Thrombotic Coating Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Medical Anti-Thrombotic Coating Sale Price by Type (2021-2026)
2.3 Medical Anti-Thrombotic Coating Segment by Coating Method
2.3.1 Dip-Coated Anti-Thrombotic Layer
2.3.2 Spray-Coated Anti-Thrombotic Layer
2.3.3 Plasma-Deposited Coating
2.3.4 Medical Anti-Thrombotic Coating Sales by Coating Method
2.3.4.1 Global Medical Anti-Thrombotic Coating Sales Market Share by Coating Method (2021-2026)
2.3.4.2 Global Medical Anti-Thrombotic Coating Revenue and Market Share by Coating Method (2021-2026)
2.3.4.3 Global Medical Anti-Thrombotic Coating Sale Price by Coating Method (2021-2026)
2.4 Medical Anti-Thrombotic Coating Segment by Durability Profile
2.4.1 Short-Term Blood-Contact Coating
2.4.2 Long-Term Implantable Coating
2.4.3 Controlled-Degradation Coating
2.4.4 Medical Anti-Thrombotic Coating Sales by Durability Profile
2.4.4.1 Global Medical Anti-Thrombotic Coating Sales Market Share by Durability Profile (2021-2026)
2.4.4.2 Global Medical Anti-Thrombotic Coating Revenue and Market Share by Durability Profile (2021-2026)
2.4.4.3 Global Medical Anti-Thrombotic Coating Sale Price by Durability Profile (2021-2026)
2.5 Medical Anti-Thrombotic Coating Segment by Application
2.5.1 Catheter
2.5.2 Stent Delivery System
2.5.3 Guide Wire
2.5.4 Others
2.5.5 Medical Anti-Thrombotic Coating Sales by Application
2.5.5.1 Global Medical Anti-Thrombotic Coating Sale Market Share by Application (2021-2026)
2.5.5.2 Global Medical Anti-Thrombotic Coating Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Medical Anti-Thrombotic Coating Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Medical Anti-Thrombotic Coating Breakdown Data by Company
3.1.1 Global Medical Anti-Thrombotic Coating Annual Sales by Company (2021-2026)
3.1.2 Global Medical Anti-Thrombotic Coating Sales Market Share by Company (2021-2026)
3.2 Global Medical Anti-Thrombotic Coating Annual Revenue by Company (2021-2026)
3.2.1 Global Medical Anti-Thrombotic Coating Revenue by Company (2021-2026)
3.2.2 Global Medical Anti-Thrombotic Coating Revenue Market Share by Company (2021-2026)
3.3 Global Medical Anti-Thrombotic Coating Sale Price by Company
3.4 Key Manufacturers Medical Anti-Thrombotic Coating Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Anti-Thrombotic Coating Product Location Distribution
3.4.2 Players Medical Anti-Thrombotic Coating Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEDICAL ANTI-THROMBOTIC COATING BY GEOGRAPHIC REGION
4.1 World Historic Medical Anti-Thrombotic Coating Market Size by Geographic Region (2021-2026)
4.1.1 Global Medical Anti-Thrombotic Coating Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Medical Anti-Thrombotic Coating Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Medical Anti-Thrombotic Coating Market Size by Country/Region (2021-2026)
4.2.1 Global Medical Anti-Thrombotic Coating Annual Sales by Country/Region (2021-2026)
4.2.2 Global Medical Anti-Thrombotic Coating Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medical Anti-Thrombotic Coating Sales Growth
4.4 APAC Medical Anti-Thrombotic Coating Sales Growth
4.5 Europe Medical Anti-Thrombotic Coating Sales Growth
4.6 Middle East & Africa Medical Anti-Thrombotic Coating Sales Growth
5 AMERICAS
5.1 Americas Medical Anti-Thrombotic Coating Sales by Country
5.1.1 Americas Medical Anti-Thrombotic Coating Sales by Country (2021-2026)
5.1.2 Americas Medical Anti-Thrombotic Coating Revenue by Country (2021-2026)
5.2 Americas Medical Anti-Thrombotic Coating Sales by Type (2021-2026)
5.3 Americas Medical Anti-Thrombotic Coating Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Anti-Thrombotic Coating Sales by Region
6.1.1 APAC Medical Anti-Thrombotic Coating Sales by Region (2021-2026)
6.1.2 APAC Medical Anti-Thrombotic Coating Revenue by Region (2021-2026)
6.2 APAC Medical Anti-Thrombotic Coating Sales by Type (2021-2026)
6.3 APAC Medical Anti-Thrombotic Coating Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Medical Anti-Thrombotic Coating by Country
7.1.1 Europe Medical Anti-Thrombotic Coating Sales by Country (2021-2026)
7.1.2 Europe Medical Anti-Thrombotic Coating Revenue by Country (2021-2026)
7.2 Europe Medical Anti-Thrombotic Coating Sales by Type (2021-2026)
7.3 Europe Medical Anti-Thrombotic Coating Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medical Anti-Thrombotic Coating by Country
8.1.1 Middle East & Africa Medical Anti-Thrombotic Coating Sales by Country (2021-2026)
8.1.2 Middle East & Africa Medical Anti-Thrombotic Coating Revenue by Country (2021-2026)
8.2 Middle East & Africa Medical Anti-Thrombotic Coating Sales by Type (2021-2026)
8.3 Middle East & Africa Medical Anti-Thrombotic Coating Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Anti-Thrombotic Coating
10.3 Manufacturing Process Analysis of Medical Anti-Thrombotic Coating
10.4 Industry Chain Structure of Medical Anti-Thrombotic Coating
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Anti-Thrombotic Coating Distributors
11.3 Medical Anti-Thrombotic Coating Customer
12 WORLD FORECAST REVIEW FOR MEDICAL ANTI-THROMBOTIC COATING BY GEOGRAPHIC REGION
12.1 Global Medical Anti-Thrombotic Coating Market Size Forecast by Region
12.1.1 Global Medical Anti-Thrombotic Coating Forecast by Region (2027-2032)
12.1.2 Global Medical Anti-Thrombotic Coating Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Medical Anti-Thrombotic Coating Forecast by Type (2027-2032)
12.7 Global Medical Anti-Thrombotic Coating Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 DSM Biomedical
13.1.1 DSM Biomedical Company Information
13.1.2 DSM Biomedical Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.1.3 DSM Biomedical Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 DSM Biomedical Main Business Overview
13.1.5 DSM Biomedical Latest Developments
13.2 Surmodics
13.2.1 Surmodics Company Information
13.2.2 Surmodics Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.2.3 Surmodics Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Surmodics Main Business Overview
13.2.5 Surmodics Latest Developments
13.3 Specialty Coating Systems (SCS)
13.3.1 Specialty Coating Systems (SCS) Company Information
13.3.2 Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.3.3 Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Specialty Coating Systems (SCS) Main Business Overview
13.3.5 Specialty Coating Systems (SCS) Latest Developments
13.4 Biocoat
13.4.1 Biocoat Company Information
13.4.2 Biocoat Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.4.3 Biocoat Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Biocoat Main Business Overview
13.4.5 Biocoat Latest Developments
13.5 Coatings2Go
13.5.1 Coatings2Go Company Information
13.5.2 Coatings2Go Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.5.3 Coatings2Go Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Coatings2Go Main Business Overview
13.5.5 Coatings2Go Latest Developments
13.6 Thermal Spray Technologies
13.6.1 Thermal Spray Technologies Company Information
13.6.2 Thermal Spray Technologies Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.6.3 Thermal Spray Technologies Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Thermal Spray Technologies Main Business Overview
13.6.5 Thermal Spray Technologies Latest Developments
13.7 Hydromer
13.7.1 Hydromer Company Information
13.7.2 Hydromer Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.7.3 Hydromer Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hydromer Main Business Overview
13.7.5 Hydromer Latest Developments
13.8 Harland Medical Systems
13.8.1 Harland Medical Systems Company Information
13.8.2 Harland Medical Systems Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.8.3 Harland Medical Systems Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Harland Medical Systems Main Business Overview
13.8.5 Harland Medical Systems Latest Developments
13.9 AST Products
13.9.1 AST Products Company Information
13.9.2 AST Products Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.9.3 AST Products Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 AST Products Main Business Overview
13.9.5 AST Products Latest Developments
13.10 Precision Coating
13.10.1 Precision Coating Company Information
13.10.2 Precision Coating Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.10.3 Precision Coating Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Precision Coating Main Business Overview
13.10.5 Precision Coating Latest Developments
13.11 Surface Solutions Group
13.11.1 Surface Solutions Group Company Information
13.11.2 Surface Solutions Group Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.11.3 Surface Solutions Group Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Surface Solutions Group Main Business Overview
13.11.5 Surface Solutions Group Latest Developments
13.12 ISurTec
13.12.1 ISurTec Company Information
13.12.2 ISurTec Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.12.3 ISurTec Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 ISurTec Main Business Overview
13.12.5 ISurTec Latest Developments
13.13 Whitford
13.13.1 Whitford Company Information
13.13.2 Whitford Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.13.3 Whitford Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Whitford Main Business Overview
13.13.5 Whitford Latest Developments
13.14 AdvanSource Biomaterials
13.14.1 AdvanSource Biomaterials Company Information
13.14.2 AdvanSource Biomaterials Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.14.3 AdvanSource Biomaterials Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 AdvanSource Biomaterials Main Business Overview
13.14.5 AdvanSource Biomaterials Latest Developments
13.15 Jiangsu Biosurf Biotech
13.15.1 Jiangsu Biosurf Biotech Company Information
13.15.2 Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.15.3 Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Jiangsu Biosurf Biotech Main Business Overview
13.15.5 Jiangsu Biosurf Biotech Latest Developments
13.16 jMedtech
13.16.1 jMedtech Company Information
13.16.2 jMedtech Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.16.3 jMedtech Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 jMedtech Main Business Overview
13.16.5 jMedtech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medical Anti-Thrombotic Coating Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Medical Anti-Thrombotic Coating by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Medical Anti-Thrombotic Coating by Country/Region, 2021, 2025 & 2032
2.2 Medical Anti-Thrombotic Coating Segment by Type
2.2.1 Thin Coating
2.2.2 Thick Coating
2.2.3 Medical Anti-Thrombotic Coating Sales by Type
2.2.3.1 Global Medical Anti-Thrombotic Coating Sales Market Share by Type (2021-2026)
2.2.3.2 Global Medical Anti-Thrombotic Coating Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Medical Anti-Thrombotic Coating Sale Price by Type (2021-2026)
2.3 Medical Anti-Thrombotic Coating Segment by Coating Method
2.3.1 Dip-Coated Anti-Thrombotic Layer
2.3.2 Spray-Coated Anti-Thrombotic Layer
2.3.3 Plasma-Deposited Coating
2.3.4 Medical Anti-Thrombotic Coating Sales by Coating Method
2.3.4.1 Global Medical Anti-Thrombotic Coating Sales Market Share by Coating Method (2021-2026)
2.3.4.2 Global Medical Anti-Thrombotic Coating Revenue and Market Share by Coating Method (2021-2026)
2.3.4.3 Global Medical Anti-Thrombotic Coating Sale Price by Coating Method (2021-2026)
2.4 Medical Anti-Thrombotic Coating Segment by Durability Profile
2.4.1 Short-Term Blood-Contact Coating
2.4.2 Long-Term Implantable Coating
2.4.3 Controlled-Degradation Coating
2.4.4 Medical Anti-Thrombotic Coating Sales by Durability Profile
2.4.4.1 Global Medical Anti-Thrombotic Coating Sales Market Share by Durability Profile (2021-2026)
2.4.4.2 Global Medical Anti-Thrombotic Coating Revenue and Market Share by Durability Profile (2021-2026)
2.4.4.3 Global Medical Anti-Thrombotic Coating Sale Price by Durability Profile (2021-2026)
2.5 Medical Anti-Thrombotic Coating Segment by Application
2.5.1 Catheter
2.5.2 Stent Delivery System
2.5.3 Guide Wire
2.5.4 Others
2.5.5 Medical Anti-Thrombotic Coating Sales by Application
2.5.5.1 Global Medical Anti-Thrombotic Coating Sale Market Share by Application (2021-2026)
2.5.5.2 Global Medical Anti-Thrombotic Coating Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Medical Anti-Thrombotic Coating Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Medical Anti-Thrombotic Coating Breakdown Data by Company
3.1.1 Global Medical Anti-Thrombotic Coating Annual Sales by Company (2021-2026)
3.1.2 Global Medical Anti-Thrombotic Coating Sales Market Share by Company (2021-2026)
3.2 Global Medical Anti-Thrombotic Coating Annual Revenue by Company (2021-2026)
3.2.1 Global Medical Anti-Thrombotic Coating Revenue by Company (2021-2026)
3.2.2 Global Medical Anti-Thrombotic Coating Revenue Market Share by Company (2021-2026)
3.3 Global Medical Anti-Thrombotic Coating Sale Price by Company
3.4 Key Manufacturers Medical Anti-Thrombotic Coating Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Anti-Thrombotic Coating Product Location Distribution
3.4.2 Players Medical Anti-Thrombotic Coating Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEDICAL ANTI-THROMBOTIC COATING BY GEOGRAPHIC REGION
4.1 World Historic Medical Anti-Thrombotic Coating Market Size by Geographic Region (2021-2026)
4.1.1 Global Medical Anti-Thrombotic Coating Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Medical Anti-Thrombotic Coating Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Medical Anti-Thrombotic Coating Market Size by Country/Region (2021-2026)
4.2.1 Global Medical Anti-Thrombotic Coating Annual Sales by Country/Region (2021-2026)
4.2.2 Global Medical Anti-Thrombotic Coating Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medical Anti-Thrombotic Coating Sales Growth
4.4 APAC Medical Anti-Thrombotic Coating Sales Growth
4.5 Europe Medical Anti-Thrombotic Coating Sales Growth
4.6 Middle East & Africa Medical Anti-Thrombotic Coating Sales Growth
5 AMERICAS
5.1 Americas Medical Anti-Thrombotic Coating Sales by Country
5.1.1 Americas Medical Anti-Thrombotic Coating Sales by Country (2021-2026)
5.1.2 Americas Medical Anti-Thrombotic Coating Revenue by Country (2021-2026)
5.2 Americas Medical Anti-Thrombotic Coating Sales by Type (2021-2026)
5.3 Americas Medical Anti-Thrombotic Coating Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Anti-Thrombotic Coating Sales by Region
6.1.1 APAC Medical Anti-Thrombotic Coating Sales by Region (2021-2026)
6.1.2 APAC Medical Anti-Thrombotic Coating Revenue by Region (2021-2026)
6.2 APAC Medical Anti-Thrombotic Coating Sales by Type (2021-2026)
6.3 APAC Medical Anti-Thrombotic Coating Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Medical Anti-Thrombotic Coating by Country
7.1.1 Europe Medical Anti-Thrombotic Coating Sales by Country (2021-2026)
7.1.2 Europe Medical Anti-Thrombotic Coating Revenue by Country (2021-2026)
7.2 Europe Medical Anti-Thrombotic Coating Sales by Type (2021-2026)
7.3 Europe Medical Anti-Thrombotic Coating Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medical Anti-Thrombotic Coating by Country
8.1.1 Middle East & Africa Medical Anti-Thrombotic Coating Sales by Country (2021-2026)
8.1.2 Middle East & Africa Medical Anti-Thrombotic Coating Revenue by Country (2021-2026)
8.2 Middle East & Africa Medical Anti-Thrombotic Coating Sales by Type (2021-2026)
8.3 Middle East & Africa Medical Anti-Thrombotic Coating Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Anti-Thrombotic Coating
10.3 Manufacturing Process Analysis of Medical Anti-Thrombotic Coating
10.4 Industry Chain Structure of Medical Anti-Thrombotic Coating
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Anti-Thrombotic Coating Distributors
11.3 Medical Anti-Thrombotic Coating Customer
12 WORLD FORECAST REVIEW FOR MEDICAL ANTI-THROMBOTIC COATING BY GEOGRAPHIC REGION
12.1 Global Medical Anti-Thrombotic Coating Market Size Forecast by Region
12.1.1 Global Medical Anti-Thrombotic Coating Forecast by Region (2027-2032)
12.1.2 Global Medical Anti-Thrombotic Coating Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Medical Anti-Thrombotic Coating Forecast by Type (2027-2032)
12.7 Global Medical Anti-Thrombotic Coating Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 DSM Biomedical
13.1.1 DSM Biomedical Company Information
13.1.2 DSM Biomedical Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.1.3 DSM Biomedical Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 DSM Biomedical Main Business Overview
13.1.5 DSM Biomedical Latest Developments
13.2 Surmodics
13.2.1 Surmodics Company Information
13.2.2 Surmodics Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.2.3 Surmodics Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Surmodics Main Business Overview
13.2.5 Surmodics Latest Developments
13.3 Specialty Coating Systems (SCS)
13.3.1 Specialty Coating Systems (SCS) Company Information
13.3.2 Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.3.3 Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Specialty Coating Systems (SCS) Main Business Overview
13.3.5 Specialty Coating Systems (SCS) Latest Developments
13.4 Biocoat
13.4.1 Biocoat Company Information
13.4.2 Biocoat Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.4.3 Biocoat Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Biocoat Main Business Overview
13.4.5 Biocoat Latest Developments
13.5 Coatings2Go
13.5.1 Coatings2Go Company Information
13.5.2 Coatings2Go Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.5.3 Coatings2Go Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Coatings2Go Main Business Overview
13.5.5 Coatings2Go Latest Developments
13.6 Thermal Spray Technologies
13.6.1 Thermal Spray Technologies Company Information
13.6.2 Thermal Spray Technologies Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.6.3 Thermal Spray Technologies Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Thermal Spray Technologies Main Business Overview
13.6.5 Thermal Spray Technologies Latest Developments
13.7 Hydromer
13.7.1 Hydromer Company Information
13.7.2 Hydromer Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.7.3 Hydromer Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Hydromer Main Business Overview
13.7.5 Hydromer Latest Developments
13.8 Harland Medical Systems
13.8.1 Harland Medical Systems Company Information
13.8.2 Harland Medical Systems Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.8.3 Harland Medical Systems Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Harland Medical Systems Main Business Overview
13.8.5 Harland Medical Systems Latest Developments
13.9 AST Products
13.9.1 AST Products Company Information
13.9.2 AST Products Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.9.3 AST Products Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 AST Products Main Business Overview
13.9.5 AST Products Latest Developments
13.10 Precision Coating
13.10.1 Precision Coating Company Information
13.10.2 Precision Coating Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.10.3 Precision Coating Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Precision Coating Main Business Overview
13.10.5 Precision Coating Latest Developments
13.11 Surface Solutions Group
13.11.1 Surface Solutions Group Company Information
13.11.2 Surface Solutions Group Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.11.3 Surface Solutions Group Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Surface Solutions Group Main Business Overview
13.11.5 Surface Solutions Group Latest Developments
13.12 ISurTec
13.12.1 ISurTec Company Information
13.12.2 ISurTec Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.12.3 ISurTec Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 ISurTec Main Business Overview
13.12.5 ISurTec Latest Developments
13.13 Whitford
13.13.1 Whitford Company Information
13.13.2 Whitford Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.13.3 Whitford Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Whitford Main Business Overview
13.13.5 Whitford Latest Developments
13.14 AdvanSource Biomaterials
13.14.1 AdvanSource Biomaterials Company Information
13.14.2 AdvanSource Biomaterials Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.14.3 AdvanSource Biomaterials Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 AdvanSource Biomaterials Main Business Overview
13.14.5 AdvanSource Biomaterials Latest Developments
13.15 Jiangsu Biosurf Biotech
13.15.1 Jiangsu Biosurf Biotech Company Information
13.15.2 Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.15.3 Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Jiangsu Biosurf Biotech Main Business Overview
13.15.5 Jiangsu Biosurf Biotech Latest Developments
13.16 jMedtech
13.16.1 jMedtech Company Information
13.16.2 jMedtech Medical Anti-Thrombotic Coating Product Portfolios and Specifications
13.16.3 jMedtech Medical Anti-Thrombotic Coating Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 jMedtech Main Business Overview
13.16.5 jMedtech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Medical Anti-Thrombotic Coating Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Medical Anti-Thrombotic Coating Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Thin Coating
Table 4. Major Players of Thick Coating
Table 5. Global Medical Anti-Thrombotic Coating Sales by Type (2021-2026) & (Kilotons)
Table 6. Global Medical Anti-Thrombotic Coating Sales Market Share by Type (2021-2026)
Table 7. Global Medical Anti-Thrombotic Coating Revenue by Type (2021-2026) & ($ million)
Table 8. Global Medical Anti-Thrombotic Coating Revenue Market Share by Type (2021-2026)
Table 9. Global Medical Anti-Thrombotic Coating Sale Price by Type (2021-2026) & (US$/Ton)
Table 10. Major Players of Dip-Coated Anti-Thrombotic Layer
Table 11. Major Players of Spray-Coated Anti-Thrombotic Layer
Table 12. Major Players of Plasma-Deposited Coating
Table 13. Global Medical Anti-Thrombotic Coating Sales by Coating Method (2021-2026) & (Kilotons)
Table 14. Global Medical Anti-Thrombotic Coating Sales Market Share by Coating Method (2021-2026)
Table 15. Global Medical Anti-Thrombotic Coating Revenue by Coating Method (2021-2026) & ($ million)
Table 16. Global Medical Anti-Thrombotic Coating Revenue Market Share by Coating Method (2021-2026)
Table 17. Global Medical Anti-Thrombotic Coating Sale Price by Coating Method (2021-2026) & (US$/Ton)
Table 18. Major Players of Short-Term Blood-Contact Coating
Table 19. Major Players of Long-Term Implantable Coating
Table 20. Major Players of Controlled-Degradation Coating
Table 21. Global Medical Anti-Thrombotic Coating Sales by Durability Profile (2021-2026) & (Kilotons)
Table 22. Global Medical Anti-Thrombotic Coating Sales Market Share by Durability Profile (2021-2026)
Table 23. Global Medical Anti-Thrombotic Coating Revenue by Durability Profile (2021-2026) & ($ million)
Table 24. Global Medical Anti-Thrombotic Coating Revenue Market Share by Durability Profile (2021-2026)
Table 25. Global Medical Anti-Thrombotic Coating Sale Price by Durability Profile (2021-2026) & (US$/Ton)
Table 26. Global Medical Anti-Thrombotic Coating Sale by Application (2021-2026) & (Kilotons)
Table 27. Global Medical Anti-Thrombotic Coating Sale Market Share by Application (2021-2026)
Table 28. Global Medical Anti-Thrombotic Coating Revenue by Application (2021-2026) & ($ million)
Table 29. Global Medical Anti-Thrombotic Coating Revenue Market Share by Application (2021-2026)
Table 30. Global Medical Anti-Thrombotic Coating Sale Price by Application (2021-2026) & (US$/Ton)
Table 31. Global Medical Anti-Thrombotic Coating Sales by Company (2021-2026) & (Kilotons)
Table 32. Global Medical Anti-Thrombotic Coating Sales Market Share by Company (2021-2026)
Table 33. Global Medical Anti-Thrombotic Coating Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Medical Anti-Thrombotic Coating Revenue Market Share by Company (2021-2026)
Table 35. Global Medical Anti-Thrombotic Coating Sale Price by Company (2021-2026) & (US$/Ton)
Table 36. Key Manufacturers Medical Anti-Thrombotic Coating Producing Area Distribution and Sales Area
Table 37. Players Medical Anti-Thrombotic Coating Products Offered
Table 38. Medical Anti-Thrombotic Coating Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Medical Anti-Thrombotic Coating Sales by Geographic Region (2021-2026) & (Kilotons)
Table 42. Global Medical Anti-Thrombotic Coating Sales Market Share Geographic Region (2021-2026)
Table 43. Global Medical Anti-Thrombotic Coating Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Medical Anti-Thrombotic Coating Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Medical Anti-Thrombotic Coating Sales by Country/Region (2021-2026) & (Kilotons)
Table 46. Global Medical Anti-Thrombotic Coating Sales Market Share by Country/Region (2021-2026)
Table 47. Global Medical Anti-Thrombotic Coating Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Medical Anti-Thrombotic Coating Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Medical Anti-Thrombotic Coating Sales by Country (2021-2026) & (Kilotons)
Table 50. Americas Medical Anti-Thrombotic Coating Sales Market Share by Country (2021-2026)
Table 51. Americas Medical Anti-Thrombotic Coating Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Medical Anti-Thrombotic Coating Sales by Type (2021-2026) & (Kilotons)
Table 53. Americas Medical Anti-Thrombotic Coating Sales by Application (2021-2026) & (Kilotons)
Table 54. APAC Medical Anti-Thrombotic Coating Sales by Region (2021-2026) & (Kilotons)
Table 55. APAC Medical Anti-Thrombotic Coating Sales Market Share by Region (2021-2026)
Table 56. APAC Medical Anti-Thrombotic Coating Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Medical Anti-Thrombotic Coating Sales by Type (2021-2026) & (Kilotons)
Table 58. APAC Medical Anti-Thrombotic Coating Sales by Application (2021-2026) & (Kilotons)
Table 59. Europe Medical Anti-Thrombotic Coating Sales by Country (2021-2026) & (Kilotons)
Table 60. Europe Medical Anti-Thrombotic Coating Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Medical Anti-Thrombotic Coating Sales by Type (2021-2026) & (Kilotons)
Table 62. Europe Medical Anti-Thrombotic Coating Sales by Application (2021-2026) & (Kilotons)
Table 63. Middle East & Africa Medical Anti-Thrombotic Coating Sales by Country (2021-2026) & (Kilotons)
Table 64. Middle East & Africa Medical Anti-Thrombotic Coating Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Medical Anti-Thrombotic Coating Sales by Type (2021-2026) & (Kilotons)
Table 66. Middle East & Africa Medical Anti-Thrombotic Coating Sales by Application (2021-2026) & (Kilotons)
Table 67. Key Market Drivers & Growth Opportunities of Medical Anti-Thrombotic Coating
Table 68. Key Market Challenges & Risks of Medical Anti-Thrombotic Coating
Table 69. Key Industry Trends of Medical Anti-Thrombotic Coating
Table 70. Medical Anti-Thrombotic Coating Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Medical Anti-Thrombotic Coating Distributors List
Table 73. Medical Anti-Thrombotic Coating Customer List
Table 74. Global Medical Anti-Thrombotic Coating Sales Forecast by Region (2027-2032) & (Kilotons)
Table 75. Global Medical Anti-Thrombotic Coating Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Medical Anti-Thrombotic Coating Sales Forecast by Country (2027-2032) & (Kilotons)
Table 77. Americas Medical Anti-Thrombotic Coating Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Medical Anti-Thrombotic Coating Sales Forecast by Region (2027-2032) & (Kilotons)
Table 79. APAC Medical Anti-Thrombotic Coating Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Medical Anti-Thrombotic Coating Sales Forecast by Country (2027-2032) & (Kilotons)
Table 81. Europe Medical Anti-Thrombotic Coating Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Medical Anti-Thrombotic Coating Sales Forecast by Country (2027-2032) & (Kilotons)
Table 83. Middle East & Africa Medical Anti-Thrombotic Coating Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Medical Anti-Thrombotic Coating Sales Forecast by Type (2027-2032) & (Kilotons)
Table 85. Global Medical Anti-Thrombotic Coating Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Medical Anti-Thrombotic Coating Sales Forecast by Application (2027-2032) & (Kilotons)
Table 87. Global Medical Anti-Thrombotic Coating Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. DSM Biomedical Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 89. DSM Biomedical Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 90. DSM Biomedical Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 91. DSM Biomedical Main Business
Table 92. DSM Biomedical Latest Developments
Table 93. Surmodics Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 94. Surmodics Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 95. Surmodics Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 96. Surmodics Main Business
Table 97. Surmodics Latest Developments
Table 98. Specialty Coating Systems (SCS) Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 99. Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 100. Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 101. Specialty Coating Systems (SCS) Main Business
Table 102. Specialty Coating Systems (SCS) Latest Developments
Table 103. Biocoat Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 104. Biocoat Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 105. Biocoat Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 106. Biocoat Main Business
Table 107. Biocoat Latest Developments
Table 108. Coatings2Go Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 109. Coatings2Go Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 110. Coatings2Go Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 111. Coatings2Go Main Business
Table 112. Coatings2Go Latest Developments
Table 113. Thermal Spray Technologies Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 114. Thermal Spray Technologies Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 115. Thermal Spray Technologies Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 116. Thermal Spray Technologies Main Business
Table 117. Thermal Spray Technologies Latest Developments
Table 118. Hydromer Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 119. Hydromer Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 120. Hydromer Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 121. Hydromer Main Business
Table 122. Hydromer Latest Developments
Table 123. Harland Medical Systems Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 124. Harland Medical Systems Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 125. Harland Medical Systems Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 126. Harland Medical Systems Main Business
Table 127. Harland Medical Systems Latest Developments
Table 128. AST Products Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 129. AST Products Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 130. AST Products Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 131. AST Products Main Business
Table 132. AST Products Latest Developments
Table 133. Precision Coating Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 134. Precision Coating Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 135. Precision Coating Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 136. Precision Coating Main Business
Table 137. Precision Coating Latest Developments
Table 138. Surface Solutions Group Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 139. Surface Solutions Group Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 140. Surface Solutions Group Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 141. Surface Solutions Group Main Business
Table 142. Surface Solutions Group Latest Developments
Table 143. ISurTec Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 144. ISurTec Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 145. ISurTec Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 146. ISurTec Main Business
Table 147. ISurTec Latest Developments
Table 148. Whitford Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 149. Whitford Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 150. Whitford Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 151. Whitford Main Business
Table 152. Whitford Latest Developments
Table 153. AdvanSource Biomaterials Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 154. AdvanSource Biomaterials Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 155. AdvanSource Biomaterials Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 156. AdvanSource Biomaterials Main Business
Table 157. AdvanSource Biomaterials Latest Developments
Table 158. Jiangsu Biosurf Biotech Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 159. Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 160. Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 161. Jiangsu Biosurf Biotech Main Business
Table 162. Jiangsu Biosurf Biotech Latest Developments
Table 163. jMedtech Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 164. jMedtech Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 165. jMedtech Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 166. jMedtech Main Business
Table 167. jMedtech Latest Developments
Table 1. Medical Anti-Thrombotic Coating Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Medical Anti-Thrombotic Coating Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Thin Coating
Table 4. Major Players of Thick Coating
Table 5. Global Medical Anti-Thrombotic Coating Sales by Type (2021-2026) & (Kilotons)
Table 6. Global Medical Anti-Thrombotic Coating Sales Market Share by Type (2021-2026)
Table 7. Global Medical Anti-Thrombotic Coating Revenue by Type (2021-2026) & ($ million)
Table 8. Global Medical Anti-Thrombotic Coating Revenue Market Share by Type (2021-2026)
Table 9. Global Medical Anti-Thrombotic Coating Sale Price by Type (2021-2026) & (US$/Ton)
Table 10. Major Players of Dip-Coated Anti-Thrombotic Layer
Table 11. Major Players of Spray-Coated Anti-Thrombotic Layer
Table 12. Major Players of Plasma-Deposited Coating
Table 13. Global Medical Anti-Thrombotic Coating Sales by Coating Method (2021-2026) & (Kilotons)
Table 14. Global Medical Anti-Thrombotic Coating Sales Market Share by Coating Method (2021-2026)
Table 15. Global Medical Anti-Thrombotic Coating Revenue by Coating Method (2021-2026) & ($ million)
Table 16. Global Medical Anti-Thrombotic Coating Revenue Market Share by Coating Method (2021-2026)
Table 17. Global Medical Anti-Thrombotic Coating Sale Price by Coating Method (2021-2026) & (US$/Ton)
Table 18. Major Players of Short-Term Blood-Contact Coating
Table 19. Major Players of Long-Term Implantable Coating
Table 20. Major Players of Controlled-Degradation Coating
Table 21. Global Medical Anti-Thrombotic Coating Sales by Durability Profile (2021-2026) & (Kilotons)
Table 22. Global Medical Anti-Thrombotic Coating Sales Market Share by Durability Profile (2021-2026)
Table 23. Global Medical Anti-Thrombotic Coating Revenue by Durability Profile (2021-2026) & ($ million)
Table 24. Global Medical Anti-Thrombotic Coating Revenue Market Share by Durability Profile (2021-2026)
Table 25. Global Medical Anti-Thrombotic Coating Sale Price by Durability Profile (2021-2026) & (US$/Ton)
Table 26. Global Medical Anti-Thrombotic Coating Sale by Application (2021-2026) & (Kilotons)
Table 27. Global Medical Anti-Thrombotic Coating Sale Market Share by Application (2021-2026)
Table 28. Global Medical Anti-Thrombotic Coating Revenue by Application (2021-2026) & ($ million)
Table 29. Global Medical Anti-Thrombotic Coating Revenue Market Share by Application (2021-2026)
Table 30. Global Medical Anti-Thrombotic Coating Sale Price by Application (2021-2026) & (US$/Ton)
Table 31. Global Medical Anti-Thrombotic Coating Sales by Company (2021-2026) & (Kilotons)
Table 32. Global Medical Anti-Thrombotic Coating Sales Market Share by Company (2021-2026)
Table 33. Global Medical Anti-Thrombotic Coating Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Medical Anti-Thrombotic Coating Revenue Market Share by Company (2021-2026)
Table 35. Global Medical Anti-Thrombotic Coating Sale Price by Company (2021-2026) & (US$/Ton)
Table 36. Key Manufacturers Medical Anti-Thrombotic Coating Producing Area Distribution and Sales Area
Table 37. Players Medical Anti-Thrombotic Coating Products Offered
Table 38. Medical Anti-Thrombotic Coating Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Medical Anti-Thrombotic Coating Sales by Geographic Region (2021-2026) & (Kilotons)
Table 42. Global Medical Anti-Thrombotic Coating Sales Market Share Geographic Region (2021-2026)
Table 43. Global Medical Anti-Thrombotic Coating Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Medical Anti-Thrombotic Coating Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Medical Anti-Thrombotic Coating Sales by Country/Region (2021-2026) & (Kilotons)
Table 46. Global Medical Anti-Thrombotic Coating Sales Market Share by Country/Region (2021-2026)
Table 47. Global Medical Anti-Thrombotic Coating Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Medical Anti-Thrombotic Coating Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Medical Anti-Thrombotic Coating Sales by Country (2021-2026) & (Kilotons)
Table 50. Americas Medical Anti-Thrombotic Coating Sales Market Share by Country (2021-2026)
Table 51. Americas Medical Anti-Thrombotic Coating Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Medical Anti-Thrombotic Coating Sales by Type (2021-2026) & (Kilotons)
Table 53. Americas Medical Anti-Thrombotic Coating Sales by Application (2021-2026) & (Kilotons)
Table 54. APAC Medical Anti-Thrombotic Coating Sales by Region (2021-2026) & (Kilotons)
Table 55. APAC Medical Anti-Thrombotic Coating Sales Market Share by Region (2021-2026)
Table 56. APAC Medical Anti-Thrombotic Coating Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Medical Anti-Thrombotic Coating Sales by Type (2021-2026) & (Kilotons)
Table 58. APAC Medical Anti-Thrombotic Coating Sales by Application (2021-2026) & (Kilotons)
Table 59. Europe Medical Anti-Thrombotic Coating Sales by Country (2021-2026) & (Kilotons)
Table 60. Europe Medical Anti-Thrombotic Coating Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Medical Anti-Thrombotic Coating Sales by Type (2021-2026) & (Kilotons)
Table 62. Europe Medical Anti-Thrombotic Coating Sales by Application (2021-2026) & (Kilotons)
Table 63. Middle East & Africa Medical Anti-Thrombotic Coating Sales by Country (2021-2026) & (Kilotons)
Table 64. Middle East & Africa Medical Anti-Thrombotic Coating Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Medical Anti-Thrombotic Coating Sales by Type (2021-2026) & (Kilotons)
Table 66. Middle East & Africa Medical Anti-Thrombotic Coating Sales by Application (2021-2026) & (Kilotons)
Table 67. Key Market Drivers & Growth Opportunities of Medical Anti-Thrombotic Coating
Table 68. Key Market Challenges & Risks of Medical Anti-Thrombotic Coating
Table 69. Key Industry Trends of Medical Anti-Thrombotic Coating
Table 70. Medical Anti-Thrombotic Coating Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Medical Anti-Thrombotic Coating Distributors List
Table 73. Medical Anti-Thrombotic Coating Customer List
Table 74. Global Medical Anti-Thrombotic Coating Sales Forecast by Region (2027-2032) & (Kilotons)
Table 75. Global Medical Anti-Thrombotic Coating Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Medical Anti-Thrombotic Coating Sales Forecast by Country (2027-2032) & (Kilotons)
Table 77. Americas Medical Anti-Thrombotic Coating Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Medical Anti-Thrombotic Coating Sales Forecast by Region (2027-2032) & (Kilotons)
Table 79. APAC Medical Anti-Thrombotic Coating Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Medical Anti-Thrombotic Coating Sales Forecast by Country (2027-2032) & (Kilotons)
Table 81. Europe Medical Anti-Thrombotic Coating Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Medical Anti-Thrombotic Coating Sales Forecast by Country (2027-2032) & (Kilotons)
Table 83. Middle East & Africa Medical Anti-Thrombotic Coating Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Medical Anti-Thrombotic Coating Sales Forecast by Type (2027-2032) & (Kilotons)
Table 85. Global Medical Anti-Thrombotic Coating Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Medical Anti-Thrombotic Coating Sales Forecast by Application (2027-2032) & (Kilotons)
Table 87. Global Medical Anti-Thrombotic Coating Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. DSM Biomedical Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 89. DSM Biomedical Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 90. DSM Biomedical Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 91. DSM Biomedical Main Business
Table 92. DSM Biomedical Latest Developments
Table 93. Surmodics Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 94. Surmodics Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 95. Surmodics Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 96. Surmodics Main Business
Table 97. Surmodics Latest Developments
Table 98. Specialty Coating Systems (SCS) Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 99. Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 100. Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 101. Specialty Coating Systems (SCS) Main Business
Table 102. Specialty Coating Systems (SCS) Latest Developments
Table 103. Biocoat Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 104. Biocoat Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 105. Biocoat Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 106. Biocoat Main Business
Table 107. Biocoat Latest Developments
Table 108. Coatings2Go Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 109. Coatings2Go Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 110. Coatings2Go Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 111. Coatings2Go Main Business
Table 112. Coatings2Go Latest Developments
Table 113. Thermal Spray Technologies Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 114. Thermal Spray Technologies Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 115. Thermal Spray Technologies Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 116. Thermal Spray Technologies Main Business
Table 117. Thermal Spray Technologies Latest Developments
Table 118. Hydromer Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 119. Hydromer Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 120. Hydromer Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 121. Hydromer Main Business
Table 122. Hydromer Latest Developments
Table 123. Harland Medical Systems Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 124. Harland Medical Systems Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 125. Harland Medical Systems Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 126. Harland Medical Systems Main Business
Table 127. Harland Medical Systems Latest Developments
Table 128. AST Products Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 129. AST Products Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 130. AST Products Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 131. AST Products Main Business
Table 132. AST Products Latest Developments
Table 133. Precision Coating Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 134. Precision Coating Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 135. Precision Coating Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 136. Precision Coating Main Business
Table 137. Precision Coating Latest Developments
Table 138. Surface Solutions Group Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 139. Surface Solutions Group Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 140. Surface Solutions Group Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 141. Surface Solutions Group Main Business
Table 142. Surface Solutions Group Latest Developments
Table 143. ISurTec Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 144. ISurTec Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 145. ISurTec Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 146. ISurTec Main Business
Table 147. ISurTec Latest Developments
Table 148. Whitford Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 149. Whitford Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 150. Whitford Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 151. Whitford Main Business
Table 152. Whitford Latest Developments
Table 153. AdvanSource Biomaterials Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 154. AdvanSource Biomaterials Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 155. AdvanSource Biomaterials Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 156. AdvanSource Biomaterials Main Business
Table 157. AdvanSource Biomaterials Latest Developments
Table 158. Jiangsu Biosurf Biotech Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 159. Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 160. Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 161. Jiangsu Biosurf Biotech Main Business
Table 162. Jiangsu Biosurf Biotech Latest Developments
Table 163. jMedtech Basic Information, Medical Anti-Thrombotic Coating Manufacturing Base, Sales Area and Its Competitors
Table 164. jMedtech Medical Anti-Thrombotic Coating Product Portfolios and Specifications
Table 165. jMedtech Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 166. jMedtech Main Business
Table 167. jMedtech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Medical Anti-Thrombotic Coating
Figure 2. Medical Anti-Thrombotic Coating Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Anti-Thrombotic Coating Sales Growth Rate 2021-2032 (Kilotons)
Figure 7. Global Medical Anti-Thrombotic Coating Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Medical Anti-Thrombotic Coating Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Medical Anti-Thrombotic Coating Sales Market Share by Country/Region (2025)
Figure 10. Medical Anti-Thrombotic Coating Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Thin Coating
Figure 12. Product Picture of Thick Coating
Figure 13. Global Medical Anti-Thrombotic Coating Sales Market Share by Type in 2026
Figure 14. Global Medical Anti-Thrombotic Coating Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Dip-Coated Anti-Thrombotic Layer
Figure 16. Product Picture of Spray-Coated Anti-Thrombotic Layer
Figure 17. Product Picture of Plasma-Deposited Coating
Figure 18. Global Medical Anti-Thrombotic Coating Sales Market Share by Coating Method in 2026
Figure 19. Global Medical Anti-Thrombotic Coating Revenue Market Share by Coating Method (2021-2026)
Figure 20. Product Picture of Short-Term Blood-Contact Coating
Figure 21. Product Picture of Long-Term Implantable Coating
Figure 22. Product Picture of Controlled-Degradation Coating
Figure 23. Global Medical Anti-Thrombotic Coating Sales Market Share by Durability Profile in 2026
Figure 24. Global Medical Anti-Thrombotic Coating Revenue Market Share by Durability Profile (2021-2026)
Figure 25. Medical Anti-Thrombotic Coating Consumed in Catheter
Figure 26. Global Medical Anti-Thrombotic Coating Market: Catheter (2021-2026) & (Kilotons)
Figure 27. Medical Anti-Thrombotic Coating Consumed in Stent Delivery System
Figure 28. Global Medical Anti-Thrombotic Coating Market: Stent Delivery System (2021-2026) & (Kilotons)
Figure 29. Medical Anti-Thrombotic Coating Consumed in Guide Wire
Figure 30. Global Medical Anti-Thrombotic Coating Market: Guide Wire (2021-2026) & (Kilotons)
Figure 31. Medical Anti-Thrombotic Coating Consumed in Others
Figure 32. Global Medical Anti-Thrombotic Coating Market: Others (2021-2026) & (Kilotons)
Figure 33. Global Medical Anti-Thrombotic Coating Sale Market Share by Application (2025)
Figure 34. Global Medical Anti-Thrombotic Coating Revenue Market Share by Application in 2025
Figure 35. Medical Anti-Thrombotic Coating Sales by Company in 2025 (Kilotons)
Figure 36. Global Medical Anti-Thrombotic Coating Sales Market Share by Company in 2025
Figure 37. Medical Anti-Thrombotic Coating Revenue by Company in 2025 ($ millions)
Figure 38. Global Medical Anti-Thrombotic Coating Revenue Market Share by Company in 2025
Figure 39. Global Medical Anti-Thrombotic Coating Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Medical Anti-Thrombotic Coating Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Medical Anti-Thrombotic Coating Sales 2021-2026 (Kilotons)
Figure 42. Americas Medical Anti-Thrombotic Coating Revenue 2021-2026 ($ millions)
Figure 43. APAC Medical Anti-Thrombotic Coating Sales 2021-2026 (Kilotons)
Figure 44. APAC Medical Anti-Thrombotic Coating Revenue 2021-2026 ($ millions)
Figure 45. Europe Medical Anti-Thrombotic Coating Sales 2021-2026 (Kilotons)
Figure 46. Europe Medical Anti-Thrombotic Coating Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Medical Anti-Thrombotic Coating Sales 2021-2026 (Kilotons)
Figure 48. Middle East & Africa Medical Anti-Thrombotic Coating Revenue 2021-2026 ($ millions)
Figure 49. Americas Medical Anti-Thrombotic Coating Sales Market Share by Country in 2025
Figure 50. Americas Medical Anti-Thrombotic Coating Revenue Market Share by Country (2021-2026)
Figure 51. Americas Medical Anti-Thrombotic Coating Sales Market Share by Type (2021-2026)
Figure 52. Americas Medical Anti-Thrombotic Coating Sales Market Share by Application (2021-2026)
Figure 53. United States Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Medical Anti-Thrombotic Coating Sales Market Share by Region in 2025
Figure 58. APAC Medical Anti-Thrombotic Coating Revenue Market Share by Region (2021-2026)
Figure 59. APAC Medical Anti-Thrombotic Coating Sales Market Share by Type (2021-2026)
Figure 60. APAC Medical Anti-Thrombotic Coating Sales Market Share by Application (2021-2026)
Figure 61. China Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 65. India Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Medical Anti-Thrombotic Coating Sales Market Share by Country in 2025
Figure 69. Europe Medical Anti-Thrombotic Coating Revenue Market Share by Country (2021-2026)
Figure 70. Europe Medical Anti-Thrombotic Coating Sales Market Share by Type (2021-2026)
Figure 71. Europe Medical Anti-Thrombotic Coating Sales Market Share by Application (2021-2026)
Figure 72. Germany Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 73. France Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Medical Anti-Thrombotic Coating Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Medical Anti-Thrombotic Coating Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Medical Anti-Thrombotic Coating Sales Market Share by Application (2021-2026)
Figure 80. Egypt Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Medical Anti-Thrombotic Coating in 2026
Figure 86. Manufacturing Process Analysis of Medical Anti-Thrombotic Coating
Figure 87. Industry Chain Structure of Medical Anti-Thrombotic Coating
Figure 88. Channels of Distribution
Figure 89. Global Medical Anti-Thrombotic Coating Sales Market Forecast by Region (2027-2032)
Figure 90. Global Medical Anti-Thrombotic Coating Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Medical Anti-Thrombotic Coating Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Medical Anti-Thrombotic Coating Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Medical Anti-Thrombotic Coating Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Medical Anti-Thrombotic Coating Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Medical Anti-Thrombotic Coating
Figure 2. Medical Anti-Thrombotic Coating Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Anti-Thrombotic Coating Sales Growth Rate 2021-2032 (Kilotons)
Figure 7. Global Medical Anti-Thrombotic Coating Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Medical Anti-Thrombotic Coating Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Medical Anti-Thrombotic Coating Sales Market Share by Country/Region (2025)
Figure 10. Medical Anti-Thrombotic Coating Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Thin Coating
Figure 12. Product Picture of Thick Coating
Figure 13. Global Medical Anti-Thrombotic Coating Sales Market Share by Type in 2026
Figure 14. Global Medical Anti-Thrombotic Coating Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Dip-Coated Anti-Thrombotic Layer
Figure 16. Product Picture of Spray-Coated Anti-Thrombotic Layer
Figure 17. Product Picture of Plasma-Deposited Coating
Figure 18. Global Medical Anti-Thrombotic Coating Sales Market Share by Coating Method in 2026
Figure 19. Global Medical Anti-Thrombotic Coating Revenue Market Share by Coating Method (2021-2026)
Figure 20. Product Picture of Short-Term Blood-Contact Coating
Figure 21. Product Picture of Long-Term Implantable Coating
Figure 22. Product Picture of Controlled-Degradation Coating
Figure 23. Global Medical Anti-Thrombotic Coating Sales Market Share by Durability Profile in 2026
Figure 24. Global Medical Anti-Thrombotic Coating Revenue Market Share by Durability Profile (2021-2026)
Figure 25. Medical Anti-Thrombotic Coating Consumed in Catheter
Figure 26. Global Medical Anti-Thrombotic Coating Market: Catheter (2021-2026) & (Kilotons)
Figure 27. Medical Anti-Thrombotic Coating Consumed in Stent Delivery System
Figure 28. Global Medical Anti-Thrombotic Coating Market: Stent Delivery System (2021-2026) & (Kilotons)
Figure 29. Medical Anti-Thrombotic Coating Consumed in Guide Wire
Figure 30. Global Medical Anti-Thrombotic Coating Market: Guide Wire (2021-2026) & (Kilotons)
Figure 31. Medical Anti-Thrombotic Coating Consumed in Others
Figure 32. Global Medical Anti-Thrombotic Coating Market: Others (2021-2026) & (Kilotons)
Figure 33. Global Medical Anti-Thrombotic Coating Sale Market Share by Application (2025)
Figure 34. Global Medical Anti-Thrombotic Coating Revenue Market Share by Application in 2025
Figure 35. Medical Anti-Thrombotic Coating Sales by Company in 2025 (Kilotons)
Figure 36. Global Medical Anti-Thrombotic Coating Sales Market Share by Company in 2025
Figure 37. Medical Anti-Thrombotic Coating Revenue by Company in 2025 ($ millions)
Figure 38. Global Medical Anti-Thrombotic Coating Revenue Market Share by Company in 2025
Figure 39. Global Medical Anti-Thrombotic Coating Sales Market Share by Geographic Region (2021-2026)
Figure 40. Global Medical Anti-Thrombotic Coating Revenue Market Share by Geographic Region in 2025
Figure 41. Americas Medical Anti-Thrombotic Coating Sales 2021-2026 (Kilotons)
Figure 42. Americas Medical Anti-Thrombotic Coating Revenue 2021-2026 ($ millions)
Figure 43. APAC Medical Anti-Thrombotic Coating Sales 2021-2026 (Kilotons)
Figure 44. APAC Medical Anti-Thrombotic Coating Revenue 2021-2026 ($ millions)
Figure 45. Europe Medical Anti-Thrombotic Coating Sales 2021-2026 (Kilotons)
Figure 46. Europe Medical Anti-Thrombotic Coating Revenue 2021-2026 ($ millions)
Figure 47. Middle East & Africa Medical Anti-Thrombotic Coating Sales 2021-2026 (Kilotons)
Figure 48. Middle East & Africa Medical Anti-Thrombotic Coating Revenue 2021-2026 ($ millions)
Figure 49. Americas Medical Anti-Thrombotic Coating Sales Market Share by Country in 2025
Figure 50. Americas Medical Anti-Thrombotic Coating Revenue Market Share by Country (2021-2026)
Figure 51. Americas Medical Anti-Thrombotic Coating Sales Market Share by Type (2021-2026)
Figure 52. Americas Medical Anti-Thrombotic Coating Sales Market Share by Application (2021-2026)
Figure 53. United States Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 54. Canada Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 55. Mexico Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 56. Brazil Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 57. APAC Medical Anti-Thrombotic Coating Sales Market Share by Region in 2025
Figure 58. APAC Medical Anti-Thrombotic Coating Revenue Market Share by Region (2021-2026)
Figure 59. APAC Medical Anti-Thrombotic Coating Sales Market Share by Type (2021-2026)
Figure 60. APAC Medical Anti-Thrombotic Coating Sales Market Share by Application (2021-2026)
Figure 61. China Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 62. Japan Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 63. South Korea Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 64. Southeast Asia Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 65. India Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 66. Australia Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 67. China Taiwan Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 68. Europe Medical Anti-Thrombotic Coating Sales Market Share by Country in 2025
Figure 69. Europe Medical Anti-Thrombotic Coating Revenue Market Share by Country (2021-2026)
Figure 70. Europe Medical Anti-Thrombotic Coating Sales Market Share by Type (2021-2026)
Figure 71. Europe Medical Anti-Thrombotic Coating Sales Market Share by Application (2021-2026)
Figure 72. Germany Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 73. France Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 74. UK Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 75. Italy Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 76. Russia Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 77. Middle East & Africa Medical Anti-Thrombotic Coating Sales Market Share by Country (2021-2026)
Figure 78. Middle East & Africa Medical Anti-Thrombotic Coating Sales Market Share by Type (2021-2026)
Figure 79. Middle East & Africa Medical Anti-Thrombotic Coating Sales Market Share by Application (2021-2026)
Figure 80. Egypt Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 81. South Africa Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 82. Israel Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 83. Turkey Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 84. GCC Countries Medical Anti-Thrombotic Coating Revenue Growth 2021-2026 ($ millions)
Figure 85. Manufacturing Cost Structure Analysis of Medical Anti-Thrombotic Coating in 2026
Figure 86. Manufacturing Process Analysis of Medical Anti-Thrombotic Coating
Figure 87. Industry Chain Structure of Medical Anti-Thrombotic Coating
Figure 88. Channels of Distribution
Figure 89. Global Medical Anti-Thrombotic Coating Sales Market Forecast by Region (2027-2032)
Figure 90. Global Medical Anti-Thrombotic Coating Revenue Market Share Forecast by Region (2027-2032)
Figure 91. Global Medical Anti-Thrombotic Coating Sales Market Share Forecast by Type (2027-2032)
Figure 92. Global Medical Anti-Thrombotic Coating Revenue Market Share Forecast by Type (2027-2032)
Figure 93. Global Medical Anti-Thrombotic Coating Sales Market Share Forecast by Application (2027-2032)
Figure 94. Global Medical Anti-Thrombotic Coating Revenue Market Share Forecast by Application (2027-2032)
